Abstracts

Predictors of late engagement to HIV care in Western Kenya: a cross-sectional study

Background: Late patient presentation contributes significantly to the high mortality reported in HIV-care and treatment programs in sub-Saharan Africa. Methodology: To assess the factors associated with late engagement we conducted a cross-sectional study using data extracted from the electronic medical records system of the Academic Model Providing Access to Healthcare (AMPATH). AMPATH provides HIV treatment…

Inhibition of Cul4A Neddylation Causes a Reversible Block to SAMHD1-Mediated Restriction of HIV-1

Background: The deoxynucleoside triphosphohydrolase SAMHD1 restricts retroviral replication in myeloid cells. It is thought to work by depleting the pool of intracellular deoxynucleotide triphosphates but has also been reported to have exonuclease activity that could allow it to degrade the viral genomic RNA or viral reverse transcribed DNA. HIV-2 and SIVmac but not HIV-1 encode…

BCA2/Rabring7 Targets HIV-1 Gag for Lysosomal Degradation in a Tetherin-Independent Manner

Background: BCA2 (Breast Cancer-Associated gene 2, Rabring7) is an E3 ubiquitin ligase that was identified as a co-factor in the restriction imposed by tetherin on HIV-1, lacking antiviral activity in the absence of tetherin. Contrary to this model, we found that BCA2 also possesses tetherin-independent antiviral activity, which leads to a reduction in the cellular…

Crystal structure of APOBEC3F elucidates HIV-1 Vif interaction and dynamic oligomerization

Background: Human APOBEC3F is an anti-retroviral ssDNA cytosine deaminase, susceptible to proteasomal degradation mediated by the HIV-1 protein Vif. Elucidating regulation of APOBEC3F and susceptibility to Vif might lead to novel approaches in antiretroviral therapy. Methodology: We determined the crystal structure of the HIV-1 Vif interacting catalytically active, C-terminal domain of human APOBEC3F and performed…

Crystal Structure of a TRIM Coiled-Coil: Implications for HIV-1 Capsid Recognition by TRIM5α

Background: TRIM5α is a cytosolic pattern-recognition receptor that intercepts incoming capsids of retroviruses, including HIV-1. Capsid recognition results in species-specific restriction of viral replication and induction of an innate immune response. The prevailing model is that TRIM5α recognizes the HIV capsid through synergy of at least 3 biochemical activities: direct binding of capsid subunits by…